Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1276 to 1290 of 1835 results for carers

  1. Standards framework for shared-decision-making support tools, including patient decision aids (ECD8)

    This document describes the framework for setting out a series of standards to support people using patient decision aids (PDAs) in assessing the usefulness and quality of a PDA. It will also be useful to those developing PDAs in enabling them to undertake a self-assessment of the quality of their tools and processes

  2. Gout: diagnosis and management (NG219)

    This guideline covers the diagnosis and management of gout. It includes recommendations on diagnosing gout, managing flares, long-term management of gout and referral to specialist services.

  3. Anticholinergic burden:- Does actively reducing anticholinergic burden in people living with dementia improve cognitive outcomes compared with usual care?

    assessment, management and support for people living with dementia and their carers Number NG97 Date issued June 2018 Other details

  4. Managing delirium superimposed on dementia:- What are the most clinically and cost-effective non-pharmacological interventions for helping the long-term recovery of people with delirium superimposed on dementia?

    assessment, management and support for people living with dementia and their carers Number NG97 Date issued June 2018 Other details

  5. Pegcetacoplan for treating geographic atrophy [ID4041]

    In development Reference number: GID-TA11351 Expected publication date: TBC

  6. NICE visualisation of treatment options incorporating technology appraisals: interim process guide (PMG38)

    This process guide explains how treatment option summaries for multiple guidelines were developed in an open, transparent, and timely way, with appropriate expert input

  7. Natalizumab (originator and biosimilar) for treating highly active relapsing–remitting multiple sclerosis after disease-modifying therapy (TA1126)

    Evidence-based recommendations on natalizumab originator (Tysabri) and biosimilar (Tyruko) for treating highly active relapsing–remitting multiple sclerosis after disease-modifying therapy in adults.

  8. Safety and safeguarding:- What safeguarding practices are most effective in improving outcomes for people using services?

    safeguarding in maintaining safety and wellbeing of service users and their carers. Analysis of routine monitoring data, for example...

  9. What information and support do people with diverticulosis, diverticular disease or acute diverticulitis need?

    diverticulosis, diverticular disease and diverticulitis and their families and carers. The evidence was from a symptom-based...

  10. Recommendation 3 Barriers and facilitators. Who should take action? Research councils, commissioners and funders. Researchers and investigators.

    aspects - socioeconomic group - gender (boys in particular) - age Ask parents, carers and families of children younger than 6 what...

  11. Evidence summaries: unlicensed and off-label medicines – Interim process statement (PMG2)

    This interim process statement sets out to guide the development of 'Evidence summaries: unlicensed and off-label medicines' (ESUOMs). It provides an overview of the key process principles and describes all stages of development for ESUOMs

  12. Support for black and minority ethnic groups:- How effective and cost effective are different approaches to supporting people from black and minority ethnic groups using intermediate care?

    experiences of people from black and minority ethnic groups, their family, carers, practitioners and voluntary support groups to inform...

  13. Models of supported living:- What is the effectiveness and cost effectiveness of models of shared, supported living, such as Shared Lives?What are the views and experiences of people sharing their home and people who live with themunder programmes such as Shared Lives?

    learning disability and behaviour that challenges and their families and carers, as well as for Shared Lives families. Source guidance...

  14. The NICE public health guidance development process (third edition) (PMG5)

    This manual describes how public health guidance is produced, and explains the stages of guidance development, the different activities, roles and responsibilities of different groups of people involved at different stages

  15. Past research and projects

    NICE's past research and projects